Spiro imidazoline compounds
    3.
    发明授权
    Spiro imidazoline compounds 失效
    螺咪唑啉化合物

    公开(公告)号:US06172097B2

    公开(公告)日:2001-01-09

    申请号:US09465619

    申请日:1999-12-17

    IPC分类号: A61K314184

    CPC分类号: C07D235/02

    摘要: The invention relates to a compound of formula (I): wherein: A represents an optionally substituted benzene ring, B represents an imidazoline ring of formula (Ia) or (Ib): and medicinal products containing the same/are useful in treating or in preventing depression, obesity, panic attacks, anxiety, obsessive-compulsive disorders, cognitive disorders, phobias, impulsive disorders associated with the abuse of drugs and withdrawal therefrom, sexual dysfunctions, and Parkinson's disease.

    摘要翻译: 本发明涉及式(I)化合物:其中:A表示任选取代的苯环,B表示式(Ia)或(Ib)的咪唑啉环:和含有该化合物的药物,可用于治疗或 预防抑郁症,肥胖症,惊恐发作,焦虑症,强迫症,认知障碍,恐怖症,与药物滥用相关的冲动性疾病和从其中退出,性功能障碍和帕金森病。

    Benzospiroalkenes
    6.
    发明授权
    Benzospiroalkenes 失效
    苯并噻唑烯

    公开(公告)号:US5486532A

    公开(公告)日:1996-01-23

    申请号:US276910

    申请日:1994-07-19

    CPC分类号: C07D235/02 C07D263/52

    摘要: Compounds of formula (I): ##STR1## in which: X represents --CH.sub.2 --, --(CH.sub.2).sub.2 --, --CH.dbd.CH--, --O--CH.sub.2 --, --S--CH.sub.2 --, --SO--CH.sub.2 -- or --SO.sub.2 --CH.sub.2 --,Y represents oxygen or sulfur or --NR.sub.5 --,R.sub.1 represents halogen, linear or branched (C.sub.1 -C.sub.6) alkyl (unsubstituted or substituted), hydroxyl or linear or branched (C.sub.1 -C.sub.6) alkoxy,R.sub.2 represents hydrogen or halogen, linear or branched (C.sub.1 -C.sub.6) alkyl (unsubstituted or substituted), hydroxyl, linear or branched (C.sub.1 -C.sub.6) alkoxy or linear or branched (C.sub.1 -C.sub.6) alkylthio,R.sub.3 represents hydrogen or halogen, linear or branched (C.sub.1 -C.sub.6) alkyl (unsubstituted or substituted), hydroxyl, linear or branched (C.sub.1 -C.sub.6) alkoxy or linear or branched (C.sub.1 -C.sub.6) alkylthio,R.sub.4 represents hydrogen or amino (unsubstituted or substituted)R.sub.5 represents hydrogen or linear or branched (C.sub.1 -C.sub.6) alkyl,or alternativelyR.sub.1 and R.sub.2 form, together with the carbon atoms which bear them, a benzenic ring, on condition that, in this case, X represents --CH.sub.2 -- or --(CH.sub.2).sub.2 --, their isomers and their addition salts with a pharmaceutically acceptable acid, and medicinal product containing the same are useful as .alpha.2-adrenergic agonist.

    摘要翻译: 式(I)化合物:其中:X表示-CH 2 - , - (CH 2)2 - , - CH = CH - , - O-CH 2 - , - S-CH 2 - ,-SO- CH 2 - 或-SO 2 -CH 2 - ,Y表示氧或硫或-NR 5 - ,R 1表示卤素,直链或支链(C 1 -C 6)烷基(未取代或取代的),羟基或直链或支链(C 1 -C 6)烷氧基, 直链或支链(C1-C6)烷基(未取代或取代的),羟基,直链或支链(C1-C6)烷氧基或直链或支链(C1-C6)烷硫基,R3代表氢或卤素, 或支链(C1-C6)烷基(未取代或取代的),羟基,直链或支链(C1-C6)烷氧基或直链或支链(C1-C6)烷硫基,R4代表氢或氨基(未取代或取代的) 直链或支链(C1-C6)烷基,或者R1和R2与带有它们的碳原子一起形成苯环,条件是在这种情况下,X表示-CH 2 - 或 - (CH 2)2 - ,它们的异构体及其加成盐 一种药学上可接受的酸,以及含有该酸的药物可用作α2-肾上腺素能激动剂。

    Benzospiroalkene compounds
    7.
    发明授权
    Benzospiroalkene compounds 失效
    苯并噻唑烯化合物

    公开(公告)号:US5648374A

    公开(公告)日:1997-07-15

    申请号:US420064

    申请日:1995-04-11

    CPC分类号: C07D235/02 C07D263/52

    摘要: Compounds of formula (I): ##STR1## in which: X represents --CH.sub.2 --, --(CH.sub.2).sub.2 --, --CH.dbd.CH--, --O--CH.sub.2 --, --S--CH.sub.2 --, --SO--CH.sub.2 -- or --SO.sub.2 --CH.sub.2 --,Y represents oxygen or sulfur or --NR.sub.5 --,R.sub.1 represents halogen, linear or branched (C.sub.1 -C.sub.6) alkyl (unsubstituted or substituted), hydroxyl or linear or branched (C.sub.1 -C.sub.6) alkoxy,R.sub.2 represents hydrogen or halogen, linear or branched (C.sub.1 -C.sub.6) alkyl (unsubstituted or substituted), hydroxyl, linear or branched (C.sub.1 -C.sub.6) alkoxy or linear or branched (C.sub.1 -C.sub.6) alkylthio,R.sub.3 represents hydrogen or halogen, linear or branched (C.sub.1 -C.sub.6) alkyl (unsubstituted or substituted), hydroxyl, linear or branched (C.sub.1 -C.sub.6) alkoxy or linear or branched (C.sub.1 -C.sub.6) alkylthio,R.sub.4 represents hydrogen or amino (unsubstituted or substituted)R.sub.5 represents hydrogen or linear or branched (C.sub.1 -C.sub.6) alkyl, or alternativelyR.sub.1 and R.sub.2 form, together with the carbon atoms which bear them, a benzenic ring, on condition that, in this case, X represents --CH.sub.2 -- or --(CH.sub.2).sub.2 --, their isomers and their addition salts with a pharmaceutically acceptable acid, and medicinal product containing the same are useful as .alpha.2-adrenergic agonist.

    摘要翻译: 式(I)化合物:其中:X表示-CH 2 - , - (CH 2)2 - , - CH = CH - , - O-CH 2 - , - S-CH 2 - ,-SO- CH 2 - 或-SO 2 -CH 2 - ,Y表示氧或硫或-NR 5 - ,R 1表示卤素,直链或支链(C 1 -C 6)烷基(未取代或取代的),羟基或直链或支链(C 1 -C 6)烷氧基, 直链或支链(C1-C6)烷基(未取代或取代的),羟基,直链或支链(C1-C6)烷氧基或直链或支链(C1-C6)烷硫基,R3代表氢或卤素, 或支链(C1-C6)烷基(未取代或取代的),羟基,直链或支链(C1-C6)烷氧基或直链或支链(C1-C6)烷硫基,R4代表氢或氨基(未取代或取代的) 直链或支链(C1-C6)烷基,或者R1和R2与带有它们的碳原子一起形成苯环,条件是在这种情况下,X表示-CH 2 - 或 - (CH 2)2 - ,它们的异构体及其加成盐 一种药学上可接受的酸,以及含有该酸的药物可用作α2-肾上腺素能激动剂。